During the past decade, Semmelweis Egyetem AOK, Szemeszeti Klinika conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Semmelweis Egyetem AOK, Szemeszeti Klinika" are "Geographic Atrophy" (3 trials), "Low-grade Serous Fallopian Tube Cancer" (1 trials), "Low-grade Serous Ovarian Cancer" (1 trials) and "Low-grade Serous Peritoneal Cancer" (1 trials). Many other conditions were trialed in "Semmelweis Egyetem AOK, Szemeszeti Klinika" in a lesser frequency.

Most popular intervention types in "Semmelweis Egyetem AOK, Szemeszeti Klinika" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lampalizumab" (2 trials), "MEK162, MEK inhibitor; oral" (1 trials), "No intervention" (1 trials), "Physician's choice chemotherapy" (1 trials) and "Sham Comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Semmelweis Egyetem AOK, Szemeszeti Klinika" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Semmelweis Egyetem AOK, Szemeszeti Klinika". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Semmelweis Egyetem AOK, Szemeszeti Klinika, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Semmelweis Egyetem AOK, Szemeszeti Klinika, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".